GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Interest Expense

Natco Pharma (NSE:NATCOPHARM) Interest Expense : ₹-130 Mil (TTM As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Natco Pharma's interest expense for the three months ended in Jun. 2024 was ₹ -52 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was ₹-130 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Natco Pharma's Operating Income for the three months ended in Jun. 2024 was ₹ 7,607 Mil. Natco Pharma's Interest Expense for the three months ended in Jun. 2024 was ₹ -52 Mil. Natco Pharma's Interest Coverage for the quarter that ended in Jun. 2024 was 146.29. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Natco Pharma Interest Expense Historical Data

The historical data trend for Natco Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Interest Expense Chart

Natco Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -177.00 -88.00 -132.00 -95.00 -120.00

Natco Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.00 -42.00 -46.00 10.00 -52.00

Natco Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-130 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natco Pharma  (NSE:NATCOPHARM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Natco Pharma's Interest Expense for the three months ended in Jun. 2024 was ₹-52 Mil. Its Operating Income for the three months ended in Jun. 2024 was ₹7,607 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was ₹0 Mil.

Natco Pharma's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2024 )/Interest Expense (Q: Jun. 2024 )
=-1*7607/-52
=146.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Natco Pharma Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Natco Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Interest Expense
Comparable Companies
BOM:543064 BOM:533573 BOM:543635 BOM:506820 BOM:540596 BOM:540222 BOM:500126 BOM:532482 BOM:532296 BOM:506943 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
524816:India
Address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Website
https://www.natcopharma.co.in
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma Headlines

No Headlines